Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A

Clinical trial NCT01027377 · COMPLETED

Trial details

NCT number: NCT01027377
Sponsor: Bioverativ Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2009-12-01
Primary completion: 2010-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.